Evaluation of Transcranial Magnetic Stimulation Efficiency in Major Depressive Disorder Patients: A Magnetic Resonance Spectroscopy Study

키워드

참고문헌 (43)

1. Wagner T, "Biophysical foundations underlying TMS : setting the stage for an effective use of neurostimulation in the cognitive neurosciences", Cortex, 45, pp.1025~1034 (2009)
2. George MS, "Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder : a sham-controlled randomized trial", Arch Gen Psychiatry, 67, pp.507~516 (2010)
3. Blumberger DM, "Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression(THREE-D) : a randomised non-inferiority trial", Lancet, 391, pp.1683~1692 (2018)
4. Pascual-Leone A, "Lateralized effect of rapid-rate rTMS of the prefrontal cortex on mood", Neurology, 46, pp.499~502 (1996)
5. George MS, "Transcranial magnetic stimulation for the treatment of depression", Expert Rev Neurother, 10, pp.1761~1772 (2010)
6. Pascual-Leoné A, "Rapid rate rTMS of left dorsolateral cortex in drug resistant depression", Lancet, 347, pp.233~237 (1996)
7. Yadollahpour A, "rTMS for the treatment of depression : a comprehensive review of effective protocols on right DLPFC", Int J Ment Health Addict, 14, pp.539~549 (2016)
8. Rodriguez-Martin JL, "Transcranial magnetic stimulation for treating depression", Cochrane Database Syst Rev, (2), pp.CD003493~ (2002)
9. Fitzgerald PB, "The effects of repetitive transcranial magnetic stimulation in the treatment of depression", Expert Rev Med Devices, 8, pp.85~95 (2011)
10. Zangen A, "Transcranial magnetic stimulation induces increases in extracellular levels of dopamine and glutamate in the nucleus accumbens", Neuroreport, 13, pp.2401~2405 (2002)
11. Tkac I, "In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T", Mag Reson Med, 62, pp.868~879 (2009)
12. Hone-Blanchet A, "Co-registration of magnetic resonance spectroscopy and transcranial magnetic stimulation", J Neurosci Methods, 242, pp.52~57 (2015)
13. Block W, "Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder : correlates and predictors of treatment response", Int J Neuropsychopharmacol, 12, pp.415~422 (2009)
14. Oğuzhanoğlu NK, "Prefrontal cortex neurochemical metabolite levels in major depression and the effects of treatment : An 1 H MRS study", Turk J Psychiatry, 25, pp.75~83 (2013)
15. Cumurcu BE, "Evaluation of neuroprotective effects of lithium and olanzapine on brain tissue in bipolar affective disorder : a comperative study with MR spectroscopy", J Anatol Psychiatry, 5, pp.197~205 (2004)
16. Speer AM, "Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients", Biol Psychiatry, 48, pp.1133~1141 (2000)
17. Padberg F, "Repetitive transcranial magnetic stimulation(rTMS)in major depression : Relation between efficacy and stimulation intensity", Neuropsychopharmacology, 27, pp.638~645 (2002)
18. Salomons TV, "Resting-state corticothalamic-striatal connectivity predicts response to dorsomedial prefrontal rTMS in major depressive disorder", Neuropsychopharmacology, 39, pp.488~498 (2014)
19. Dubin MJ, "Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy", J Psychiatry Neurosci, 41, pp.E37~ (2016)[DOI]
20. Herwig U, "Using the international 10–20 EEG system for positioning of transcranial magnetic stimulation", Brain Topogr, 16, pp.95~99 (2003)
21. Angelie E, "Regional differences and metabolic changes in normal aging of the human brain : Proton MR spectroscopic imaging study", Am J Neuroradiol, 22, pp.119~127 (2001)
22. Koenigs M, "The functional neuroanatomy of depression : distinct roles for ventromedial and dorsolateral prefrontal cortex", Behav Brain Res, 201, pp.239~243 (2009)
23. Wang Y, "Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive 61 disorder : a proton magnetic resonance spectroscopy study", J Affect Disord, 136, pp.620~626 (2012)
24. Chen LP, "Anterior cingulate cortex and cerebellar hemisphere neurometabolite changes in depression treatment : A H magnetic resonance spectroscopy study", Psychiatry Clin Neurosci, 68, pp.357~364 (2014)
25. Abdallah CG, "Decreased occipital cortical glutamate levels in response to successful cognitive behavioral therapy and pharmaco therapy for major depressive disorder", Psychother Psychosom, 83, pp.289~307 (2014)
26. Vythilingam M, "Focal and lateralized subcortical abnormalities in unipolar major depressive disorder : an automated multivoxel proton magnetic resonance spectroscopy study", Biol Psychiatry, 54, pp.744~750 (2003)
27. De Diego-Adelino J, "Hippocampal abnormalities of glutamate", glutamine, N-acetylaspartate and choline in patients with depression are related to a stillness burden, 2013, pp.38, 107~116
28. Wu WE, "Whole brain N-acetylaspartate concentration is conserved throughout normal aging", Neurobiol Aging, 33, pp.2440~2447 (2012)
29. Jia Y, "The correlation between biochemical abnormalities in frontal white matter, hippocampus and serum thyroid 76 hormone levels in first-episode patients with major depressive disorder", J Affect Disord, 180, pp.162~169 (2015)
30. Moore GJ, "Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects?", Biol Psychiatry, 48, pp.1~8 (2000)
31. Sonawalla SB, "Compounds containing cytosolic choline in the basal ganglia : A potential biological marker of true drug response to fluoxetine", Am J Psychiatry, 156, pp.1638~1640 (1999)
32. Auer DP, "Reduced glutamate in the anterior cingulate cortex in depression : an in vivo proton magnetic resonance spectroscopy study", Biol Psychiatry, 47, pp.305~313 (2000)
33. Gönül AS, "The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug free depressed patients", Prog Neuropsychopharmacol Biol Psychiatry, 30, pp.120~125 (2006)
34. Zhang Y, "A MRS study of metabolic alterations in the frontal white matter of major depressive disorder patients with the treatment of SSRIs", BMC Psychiatry, 15, pp.99~ (2015)
35. Herman-Sucharska I, "Usefulness of proton MR spectroscopy for determining diagnosis and treatment outcome in unipolar depressive disorder", Przegl Lek, 67, pp.243~246 (2010)
36. Son H, "Glutamine has antidepressive effects through increments of glutamate and glutamine levels and glutamatergic activity in the medial prefrontal cortex", Neuropharmacology, 25, pp.143~152 (2018)
37. Lee Y, "Glutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male mice", J Psychiatry Neurosci, 38, pp.183~191 (2013)
38. Michael N, "Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression", Psychol Med, 33, pp.1277~1284 (2003)
39. Dringen R, "Metabolism and functions of glutathione in brain", Prog Neurobiol, 62, pp.649~671 (2000)
40. Behr GA, "Preclinical and clinical evidence of antioxidant effects of antidepressant agents : implications for the pathophysiology of major depressive disorder", Oxid Med Cell Longev, 2012, pp.609421~ (2012)
41. Bilici M, "Antioxidative enzyme activities and lipid peroxidation in major depression : alterations by antidepressant treatments", J Affect Disord, 64, pp.43~51 (2001)
42. Magalhães PV, "N-acetyl cysteine add-on treatment for bipolar II disorder : a subgroup analysis of a randomized placebo-controlled trial", J Affect Disord, 129, pp.317~320 (2011)
43. Slattery J, "Clinical trials of N-acetylcysteine in psychiatry and neurology : A systematic review", Neurosci Biobehav Rev, 55, pp.294~321 (2015)

관련 논문AI추천